Clinical Trials Browser

Nasopharyngeal Carcinoma × camrelizumab × 30 days × Clear all

NCT06239727 2026-03-06

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

Phase 3 Recruiting

Nasopharyngeal Carcinoma